| Return Create A Forum - Home | |
| --------------------------------------------------------- | |
| MS Speaks | |
| https://msspeaks.createaforum.com | |
| --------------------------------------------------------- | |
| ***************************************************** | |
| Return to: KESIMPTA (ofatumumab) | |
| ***************************************************** | |
| #Post#: 3724-------------------------------------------------- | |
| (Abst.) Efficacy and safety of ofatumumab in recently diagnosed, | |
| treatment-naive MS patients | |
| By: agate Date: July 26, 2022, 1:25 am | |
| --------------------------------------------------------- | |
| From Multiple Sclerosis Journal (September 1, 2022)--"Efficacy | |
| and safety of ofatumumab in recently diagnosed ... patients with | |
| multiple sclerosis: Results from ASCLEPIOS I and II": | |
| https://journals.sagepub.com/doi/full/10.1177/13524585221078825 | |
| ***************************************************** |